BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31898669)

  • 1. Comparison of volume doses from conventional two-dimensional brachytherapy with corresponding doses from three-dimensional magnetic resonance imaging-based brachytherapy in carcinoma cervix.
    Mathews S; Azariah MB; Mohandas S; Menon SV; George P; Jayaprakash PG
    J Cancer Res Ther; 2019; 15(6):1332-1337. PubMed ID: 31898669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
    Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
    Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
    Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
    Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
    Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
    Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric analysis of 3D image-guided HDR brachytherapy planning for the treatment of cervical cancer: is point A-based dose prescription still valid in image-guided brachytherapy?
    Kim H; Beriwal S; Houser C; Huq MS
    Med Dosim; 2011; 36(2):166-70. PubMed ID: 20488690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experience.
    Simha V; Rai B; Patel FD; Kapoor R; Sharma SC; Singh OA; Singla V; Dhanireddy B; Ghoshal S
    Brachytherapy; 2018; 17(2):345-351. PubMed ID: 29102740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment.
    Wu A; Tang D; Wu A; Liu Y; Qian L; Zhu L
    Technol Cancer Res Treat; 2021; 20():15330338211041201. PubMed ID: 34569371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
    Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single magnetic resonance imaging vs magnetic resonance imaging/computed tomography planning in cervical cancer brachytherapy.
    Beriwal S; Kim H; Coon D; Mogus R; Heron DE; Li X; Huq MS
    Clin Oncol (R Coll Radiol); 2009 Aug; 21(6):483-7. PubMed ID: 19423307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric comparison of
    Shukla AK; Jangid PK; Rajpurohit VS; Verma A; Dangayach SK; Gagrani V; Rathore NK
    J Cancer Res Ther; 2019; 15(6):1212-1215. PubMed ID: 31898649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-fractional dosimetric analysis of image-guided intracavitary brachytherapy of cervical cancer.
    Yan J; Zhu J; Chen K; Yu L; Zhang F
    Radiat Oncol; 2021 Aug; 16(1):144. PubMed ID: 34348758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
    Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
    Lindegaard JC; Tanderup K; Nielsen SK; Haack S; Gelineck J
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):756-64. PubMed ID: 18191335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction.
    Nesvacil N; Pötter R; Sturdza A; Hegazy N; Federico M; Kirisits C
    Radiother Oncol; 2013 Apr; 107(1):75-81. PubMed ID: 23068712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
    Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S
    Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can MRI-only replace MRI-CT planning with a titanium tandem and ovoid applicator?
    Harkenrider MM; Patel R; Surucu M; Chinsky B; Mysz ML; Wood A; Ryan K; Shea SM; Small W; Roeske JC
    Brachytherapy; 2018; 17(5):747-752. PubMed ID: 29945764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single line source with and without vaginal loading and the impact on target coverage and organ at risk doses for cervix cancer Stages IB, II, and IIIB: treatment planning simulation in patients treated with MRI-guided adaptive brachytherapy in a multicentre study (EMBRACE).
    Nkiwane KS; Pötter R; Tanderup K; Federico M; Lindegaard JC; Kirisits C
    Brachytherapy; 2013; 12(4):317-23. PubMed ID: 23474352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
    Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
    Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.